Ostatnia aktualizacja :
08/05/2024
Znieczulenie ogólne   Ketamine hydrochloride  
Injekcje
Roztwór doustny
Trwałość roztworów Trwałość w mieszaninie Czynnik wpływający na trwałość Zgodność Sposób podania Bibliografia Pdf
   Struktura chemiczna  

Nazwa handlowa   Nazwa handlowa     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Aescoket Włochy
Anesket KolumbiaKolumbia, Meksyk
Calypsol Malezja, Polska, Rumunia, Tajlandia, Węgry
Inducmina Argentyna, Peru
Kanox Malezja
Keiram Egipt, Wenezuela
Keta Indie, Niemcy
Keta Hameln Peru
Ketafast Indie
Ketajet Indie
Ketalar Australia, Belgia, Brazylia, Chile, Dania, Finlandia, Holandia, Irlandia, Kanada, KolumbiaKolumbia, Luksemburg, Norwegia, Nowa Zelandia, Portugalia, Stany Zjednoczone Ameryki, Szwecja, Turcja, Wielka Brytania, Zjednoczone Emiraty Arabskie
Ketalin Meksyk
Ketamar Egipt
Ketamax Indie, Wenezuela
Ketamin Niemcy
Ketamina Argentyna, Chile, KolumbiaKolumbia, Peru, Wenezuela
Ketamine Egipt, Francja , Irlandia, Kanada, Malezja, Nowa Zelandia, Rumunia, Stany Zjednoczone Ameryki, Tunisie, Włochy
Ketanest Polska
Ketanir Ekwador, KolumbiaKolumbia, Peru
Ketashort KolumbiaKolumbia
Ketava Malezja
Ketmin Indie
Ketolar Hiszpania
Ketsia Indie
Kmin Indie
Tekam Arabia Saudyjska, Zjednoczone Emiraty Arabskie
Bibliografia   Injekcje   Bibliografia : Ketamine hydrochloride  
Typ Publikacja
181 Czasopismo Fuchao Chen, Hui Xiong, Jinguo Yang, Baoxia Fang, Jun Zhu, Benhong Zhou.
Butorphanol and Ketamine Combined in Infusion Solutions for Patient-Controlled Analgesia Administration: A Long-Term Stability Study.
Med Sci Monit 2015 ; 21:1138-1145.
300 Czasopismo Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
321 Czasopismo Ambados F.
Compatibility of ketamine hydrochloride and meperidine hydrochloride.
Am J Health-Syst Pharm 1997 ; 54: 205.
365 Czasopismo Junfeng Gu, Wengang Qin, Fuchao Chen, Zhongyuan Xia.
Long-Term Stability of Tramadol and Ketamine Solutions for Patient-Controlled Analgesia Delivery.
Med Sci Monit 2015 ; 21:2528-2534.
660 Czasopismo Michaels MR, Stauffer GL, Haas DP.
Propofol compatibility with other intravenous drug products - Two new methods of evaluating IV emulsion compatibility.
Ann Pharmacotherapy 1996 ; 30: 228-232.
980 Czasopismo Ambados F.
Compatibility of morphine and ketamine for subcutaneous infusion.
Aust J Hosp Pharm 1995 ; 25: 352.
1714 Czasopismo Gupta VD.
Stability of ketamine hydrochloride injection after reconstitution in water for injection and storage in 1-ml tuberculin polypropylene syringes for pediatric use.
Int J Pharm Compound 2002 ; 6: 316-317.
1759 Czasopismo Servais H, Tulkens PM.
Stability and compatibility of ceftazidime administered by continuous infusion to intensive care patients.
Antimicrob Agents Chemother 2001 ; 45: 2643-2647.
1864 Czasopismo Lau MH, Hackman C, Morgan DJ.
Compatibility of ketamine and morphin injections.
Pain 1998 ; 75: 389-390.
1934 Czasopismo Ambados F, Brealey J.
Compatibility of ketamine hydrochloride and fentanyl citrate in polypropylene syringes.
Am J Health-Syst Pharm 2004 ; 61: 1438-1445.
1993 Czasopismo Lee DKT, Wang DP, Harsono R, Wong CY.
Compatibility of fentanyl citrate, ketamine hydrochloride, and droperidol in 0.9% sodium chloride injection stored in polyvinyl chloride bags.
Am J Health-Syst Pharm 2005 ; 62: 1190-1192.
2022 Czasopismo Watson DG, Lin M, Morton A, Cable CG, McArthur DA.
Compatibility and stability of dexamethasone sodium phosphate and ketamine hydrochloride subcutaneous infusions in polypropylene syringes.
J Pain Symptom Manage 2005 ; 30: 80-86.
2109 Czasopismo Pelletier E, Forest JM, Hildgen P.
Compatibilité de la kétamine injectable lors de l’administration en dérivé avec d’autres médicaments usuels.
Pharmactuel 2006 ; 39: 71-75.
2141 Czasopismo Barinian N, Chanteux H, Viaene E, Servais H, Tulkens PM.
Stability and compatibility study of cefepime in comparaison with ceftazidime for potential administration by continuous infusion under conditions pertinent to ambulatory treatment of cystic fibrosis patients and to administration in intensive care units.
J Antimicrob Chemother 2003 ; 51: 651-658.
2231 Czasopismo de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2287 Czasopismo Stucki MC, Leury-Souverain S, Sautter AM, Sadeghipour F, Bonnabry P.
Development of ready-to-use ketamine hydrochloride syringes for safe use in post-operative pain.
EJHP Science 2008 ; 14, 1: 14-18.
2322 Czasopismo Donnelly R.F.
Physical Compatibility and Chemical Stability of Ketamine–Morphine Mixtures in Polypropylene Syringes.
Can J Hosp Pharm 2009 ; 62, 1
2329 Czasopismo Donnely R.F, Willman E, Andolfatto G.
Stability of Ketamine-Propofol mixtures for procedural sedation and analgesia in the emergency department.
Can J Hosp Pharm 2008 ; 61, 6: 426-430.
2336 Czasopismo Ensom M.H.H, Decarie D, Leung K, MontgomeryC
Stability of Hydromorphone–Ketamine Solutions in Glass Bottles, Plastic Syringes, and IV Bags for Pediatric Use
Can J Hosp Pharm 2009 ; 62, 2: 112-118.
2350 Czasopismo Roy J.J, Hildgen P.
Stability of morphine-ketamine in 0.9% sodium chloride injection packaged in syringes, plastic bags and MEDICATION CASSETTE Reservoirs.
Int J Pharm Compound 2000 ; 4, 3: 225-228.
2900 Czasopismo Hines S, Pleasance S.
Compatibility of an injectable high strength oxycodone formulation with typical diluents, syringes, tubings,infusion bags and drugs for potential co-administration.
EJHP 2009 ; 15, 5: 32-38.
3012 Czasopismo Sullivan T, Forrest J.M, Leclair G.
Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration
Hosp Pharm 2015 ; 50, 3: 214-220.
3372 Czasopismo Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S.
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3385 Czasopismo Raverdi V, Ampe E, Hecq JD, Tulkens PM.
Stability and compatibility of vancomycin for administration by continuous infusion.
J Antimicrob Chemother 2013 ; 68: 1179-1182.
3408 Czasopismo Tollec S, Touzin K, Pelletier E, Forest J.M.
Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels.
Pharmactuel 2013 ; 46, 1 : 16-21.
3435 Czasopismo Donnelly R.F.
Stability of Diluted Ketamine Packaged in Glass Vials.
Can J Hosp Pharm 2013 ; 66, 3 : 198.
3501 Laboratorium Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics
Pfizer 2011
3705 Czasopismo Knudsen L, Eisend S, Haake N, Kunze T.
Physicochemical compatibility of commonly used analgesics and sedatives in the intensive care medicine.
EJHP 2014 ;21:161-166
3824 Czasopismo Boudi S, Roy H, Forest JM, Leclair G.
Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y.
Pharmactuel 2023 2023;56,3:91-98
3859 Czasopismo Foy G, Poinsignon V, Mercier L, Laurent S, Paci A.
Microbiological and Physico-Chemical Stability of Ketamine Solution for Patient-Controlled Analgesia Systems.
RRJHCP 2016 ; 1, 3: 31-37.
3874 Czasopismo Huvelle S, Godet M, Hecq J.D, Gillet P, Bihin B, Jamart J, Galanti L.
Long-term stability of ketamine hydrochloride 50 mg/ml injection in 3 ml syringes
Ann Pharm Fr 2016 ; 74: 283-287.
3911 Czasopismo Closset M, Hecq J D, Gonzalez E, Bihin B, Jamart J, L Galanti L.
Does an interaction exist between ketamine hydrochloride and Becton Dickinson syringes?
EJHP 2017 ; 24: 230-234.
3932 Laboratorium Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit
Serb Laboratoire 2015
3964 Czasopismo Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G.
Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments.
Pharmactuel 2017 ; 50,1 : 27-33.
4011 Czasopismo Gersonde F, Eisend S, Haake N, Kunze T.
Physicochemical compatibility and emulsion stability of propofol with commonly used analgesics and sedatives in an intensive care unit.
EJHP 2016 2016;0:1-11
4115 Czasopismo Fang B, Wang L, Gu J, Chen F, Shi X.
Physicochemical stability of ternary admixtures of butorphanol, ketamine, and droperidol in polyolefin bags for patient-controlled analgesia use.
Drug Design Dev Ther 2016 ;10:3873-3878
4143 Czasopismo Daouphars M, Hervou?t C.H, Bohn P, Martin D, Rouvet J, Basuyau F, Varin R.
Physicochemical stability of oxycodone-ketamine solutions in polypropylene syringe and polyvinyl chloride bag for patient-controlled analgesia use.
EJHP 2016 ; 25, 4
4157 Czasopismo Izgi M, Basara B, Muderrisoglu A, Yilbas A.A, Uluer M.S, Celebioglu B.
Evaluation of the stability and stratification of propofol and ketamine mixtures for pediatric anesthesia.
Pediatric Anesthesia 2018
4303 Czasopismo Anderson C, MacKay M.
Stability of Fentanyl Citrate, Hydromorphone Hydrochloride, Ketamine Hydrochloride, Midazolam, Morphine Sulfate, and Pentobarbital Sodium in Polypropylene Syringes.
Pharmacy 2015 3, 379-385.
4319 Czasopismo Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4350 Czasopismo Beiler B, Barraud D, Vigneron J, Demor? B.
Physicochemical stability of an admixture of lidocaine and ketamine in polypropylene syringe used in opioid-free anaesthesia.
EJHP 2019 ;0:1-5
4389 Czasopismo Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G.
Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine.
Pharmactuel 2019 ;52,4:206-213
4435 Czasopismo Hanifah S, Nugroho B.H, Chabib L.
Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection.
Anaesthesiol Intensive Ther 2020 ; 52, 1: 23-27.
4436 Czasopismo Hanifah S, Kennedy R.A; Ball P.A.
Extended compatibility of fentanyl and ketamine in dextrose 5%.
Anaesthesiol Intensive Ther 2018 ; 50, 3: 221-225.
4491 Czasopismo De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pilar P, De Miguel M, Campino A.
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
Eur J Pedia 2020
4507 Czasopismo Ross E, Salinas A, Petty K, Her C, Carpenter J.
Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing.
Am J Health-Syst Pharm 2020 ;77,23:1980-1985
4603 Czasopismo Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G.
Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration.
Hosp Pharm 2021 ; 56, 4: 228-234.
4651 Czasopismo De Basagoiti A, Katsumiti A, Abascal S, Bustinza A, López-Giménez L.R, Pascual P, De Miguel M, Campino A.
Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units.
Eur J Pedia 2021 ;180,1169–1176.
4742 Czasopismo Macoviciuc M, Nguyen C, Forest J-M, Leclair G.
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Pharmactuel 2022 ; 55, 4: 247-255.

  Mentions Légales